RecruitingNot applicableFemale onlyEN originalBreast cancerHormone receptor positive (HR+)Early / localized

Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This is a national clinical trial (Spain), conducted in approximately 5 sites, where patients who agree to participate will be included in one of two exercise program groups: the experimental group (a combined resistance and aerobic exercise program) and the control group. The study will begin with a pilot phase involving approximately 74 patients. Approximately 37 patients in the experimental group will follow a 6-month training program consisting of exercise sessions three alternate days per week (combining resistance and aerobic exercise). Approximately 37 patients in the control group will receive standard medical care. These patients will be provided with international exercise guidelines for cancer patients. Patients will continue with their assigned physical activity intervention until the maximum number of months for the intervention, unacceptable toxicity, discontinuation of hormone therapy, or withdrawal of consent-whichever occurs first.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Pacjentka musi wyrazić zgodę na udział w badaniu i stosować się do zaleceń.
  • Pacjentka musi mieć ukończone 18 lat.
  • Pacjentka musi mieć zdiagnozowanego raka piersi, potwierdzonego badaniami, który nie rozprzestrzenił się na inne części ciała.
  • Pacjentka musi być w dobrym ogólnym stanie zdrowia (w skali ECOG 0-2).
  • Pacjentka musi być po leczeniu hormonalnym AI od 10 do 18 tygodni (z lub bez dodatkowego leczenia).
  • Pacjentka musi być po leczeniu miejscowym raka piersi (operacja, z radioterapią lub bez).
  • Pacjentka musi mieć prawidłowe wyniki badań krwi i szpiku kostnego.
  • Pacjentka musi być zdolna i chętna do wypełniania ankiet dotyczących jakości życia, bólu i zmęczenia oraz do przestrzegania zaleceń dotyczących aktywności fizycznej.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 29, 2026
Sex
Female only

Therapies / drugs in trial

Locations (5)

Institut Català d'Oncología (ICO) L'Hospitalet

L'Hospitalet de Llobregat, Spain

Hospital Universitario de Navarra

Pamplona, Spain

Hospital Universitario Clínico San Cecilio

Granada, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Quirón Sagrado Corazón de Sevilla

Seville, Spain

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/31/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.